Next Article in Journal
Refolding Technology for scFv Using a New Detergent, N-Lauroyl-L-glutamate and Arginine
Next Article in Special Issue
Immunotherapy of B-Cell Lymphoma with an Engineered Bispecific Antibody Targeting CD19 and CD5
Previous Article in Journal / Special Issue
Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs
Antibodies 2012, 1(2), 199-214; doi:10.3390/antib1020199

Dual Targeting of Tumor Cells with Bispecific Single-Chain Fv-Immunoliposomes

1, 2, 1, 1 and 1,*
1 Institut für Zellbiologie und Immunologie, Universität Stuttgart, Allmandring 31, 70569 Stuttgart, Germany 2 Institut für Pharmazie, Friedrich-Schiller Universität Jena, Lessingstraße 8, 07743 Jena, Germany
* Author to whom correspondence should be addressed.
Received: 8 May 2012 / Revised: 9 July 2012 / Accepted: 13 July 2012 / Published: 25 July 2012
(This article belongs to the Special Issue Bispecific Antibodies for Dual Targeting Strategies)
View Full-Text   |   Download PDF [799 KB, uploaded 25 July 2012]   |   Browse Figures


Antibody fragments, especially single-chain Fv fragments, have been established for the generation of immunoliposomes for targeted drug delivery in cancer therapy and other applications. Bispecific immunoliposomes should be useful for dual targeting addressing inter- and intratumoral heterogeneity of tumor antigen expression. Here, we established a protocol to generate dual-targeted immunoliposomes using genetically engineered scFv molecules recognizing two different tumor-associated antigens, EGFR and CEA (CEACAM5), applying a step-wise insertion of antibody-coupled micelles into preformed PEGylated liposomes. The dual-targeted immunoliposomes retained binding activity for both antigens and combined the selectivity of both antibodies within one liposome. Thus, these dual-targeted immunoliposomes should be suitable to deliver therapeutic payloads to tumor cells expressing EGFR or CEA, or both antigens.
Keywords: dual targeting; bispecific immunoliposomes; single-chain Fv fragments; tumor targeting dual targeting; bispecific immunoliposomes; single-chain Fv fragments; tumor targeting
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Mack, K.; Rüger, R.; Fellermeier, S.; Seifert, O.; Kontermann, R.E. Dual Targeting of Tumor Cells with Bispecific Single-Chain Fv-Immunoliposomes. Antibodies 2012, 1, 199-214.

View more citation formats

Related Articles

Article Metrics


Cited By

[Return to top]
Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert